Effects of Exercise and Metformin on Methylglyoxal Levels in Prediabetic Individuals

Sultan Abdulhamid Han Training and Research Hospital, Istanbul, Turkey

Status: Completed

Conditions: Methylglyoxal; Metformin; Exercise; PreDiabetes

Treatments: Behavioral: Exercise; Other: Metformin

Study type: Interventional

Funder types: Other

Identifiers

NCT06603480

MEGS

Details and patient eligibility

About

The aim of this study is to compare the effects of exercise, standard lifestyle changes and metformin on MGO in prediabetic individuals.

Full description

There is no comparative study in the literature evaluating the effects of exercise and metformin on MGO in prediabetic patients. The aim of this study is to compare the effects of exercise, standard lifestyle changes and metformin on MGO in prediabetic individuals.

Enrollment: 96 patients

Sex: All

Ages: 18 to 60 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Patients who were newly diagnosed with prediabetes by Oral Glucose Tolerance Test (OGTT) and/or HbA1C,
• who were assessed as physically inactive (Level 1) according to the International Physical Activity Questionnaire
• who had sufficient motivation to participate in the exercise program (assessed by one-on-one interviews conducted by the researchers),
• who were deemed suitable to participate in the exercise program after a cardiac examination by a cardiologist (with resting electrocardiogram and questioning of cardiac symptoms, and advanced tests such as exercise electrocardiogram test when necessary),
• who had the same weight (±2.5 kg) for 6 months before participating in the study.

Exclusion criteria

• having a serious medical condition that would prevent the person from participating in the exercise study (e.g. advanced malignancy or major neurological, psychiatric or endocrine disease, respiratory failure, etc.),
• having used metformin for 6 months before the study, having cardiovascular disease,
• heart failure, cancer, having a BMI <19 kg/m2, receiving hormone replacement therapy,
• having a life expectancy of less than 1 year, being HIV positive, substance use,
• functional dependence, having an orthopedic disease that prevents physical activity,
• having cognitive impairment and other diseases that would affect the study results (respiratory diseases, muscle diseases, non-alcoholic fatty liver disease, etc.),
• using medications or supplements that would affect the study results.

Trial design

Primary purpose: Treatment

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: Single Blind

---

96 participants in 3 patient groups

Aerobic Exercise

Active Comparator group

Description:

12 week aerobic exercise

Treatment:

Behavioral: Exercise

Metformin

Experimental group

Description:

Metformin 2\*1 given

Treatment:

Other: Metformin

Control

No Intervention group

Description:

Only routine